A Phase 3b, open-labeled, randomized, parallel-group, multi-center study to evaluate the safety of novartis MenACWY Conjugate Vaccine when administered with routine infant Vaccinations to healthy Infants

drug protocol number
V59P23
drug sponsor
Novartis
drug study
Meningococcal ACWY Conjugate Vaccine
drug trial site
KFMC
drug status
Completed
drug phase